Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 939,900	$ 1,066,900
Restricted cash	15,100	16,300
Accounts receivable, less allowances of $11,100 and $11,600, respectively	452,600	479,600
Inventories	364,200	356,200
Short-term deferred tax assets	71,500	78,200
Other current assets	97,900	93,200
Total current assets	1,941,200	2,090,400
Property, plant and equipment, at cost	687,000	667,500
Less accumulated depreciation and amortization	291,200	276,300
Net property, plant and equipment	395,800	391,200
Goodwill	1,102,100	1,099,500
Core and developed technologies, net	677,700	696,800
Other intangible assets, net	460,900	468,100
Deferred tax assets	8,200	3,900
Other assets	292,000	291,200
Total assets	4,877,900	5,041,100
Current liabilities
Accounts payable	90,400	83,000
Accrued expenses	323,000	294,000
Accrued compensation and benefits	101,900	145,300
Income taxes payable	16,400	64,200
Total current liabilities	531,700	586,500
Long-term debt	1,404,800	1,405,700
Other long-term liabilities	715,400	798,800
Deferred income taxes	169,800	161,900
Commitments and contingencies
Shareholders' investment:
Preferred stock, $1 par value, authorized 5,000,000 shares; none issued	0	0
Common stock, $0.25 par value, authorized 600,000,000 shares; issued and outstanding 76,257,057 shares at March 31, 2014 and 77,436,263 shares at December 31, 2013	19,100	19,400
Capital in excess of par value	1,801,700	1,729,600
Retained earnings	253,300	360,100
Accumulated other comprehensive loss	(17,900)	(20,900)
Total shareholders' investment	2,056,200	2,088,200
Total liabilities and shareholders' investment	$ 4,877,900	$ 5,041,100